4.7 Article

A PDA-DTC/Cu-MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment

Journal

CHEMICAL COMMUNICATIONS
Volume 57, Issue 34, Pages 4158-4161

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1cc00987g

Keywords

-

Funding

  1. National Nature Science Foundation of China [21877084, 21671150, 81171646, 31170776, 21472139, 82003283]
  2. Science and Technology Commission of Shanghai Municipality [14DZ2261100]
  3. Fundamental Research Funds for the Central Universities [kx0150720173382]

Ask authors/readers for more resources

A multi-functional nanoplatform (PDA-DTC/Cu-MnO2) was developed for MR imaging-guided multi-therapy (CDT, PTT, and chemotherapy) in cancer treatment. Both in vitro and in vivo results confirmed the biocompatible nanoplatform's ability to significantly induce tumor cell death and inhibit tumor growth.
Herein, a multi-functional nanoplatform (PDA-DTC/Cu-MnO2) was established, which has been employed for MR imaging-guided multi-therapy (CDT, PTT and chemotherapy) for cancer treatment. The in vitro and in vivo results confirmed that the biocompatible nanoplatform could significantly induce tumor cell death and inhibit tumor growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available